UCAR-T
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for UCAR-T, covering 2026-03-02 to 2026-03-02. Get the full timeline:
Most recent: Clinical Trial Update: UCAR-T Targeting CD19/BCMA in Subjects With Autoantibody-Mediated Autoimmune Benign Hematological Diseases [EARLY_Phase 1]